Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Sempra Energy Q4 2025 Earnings Call - $65B CapEx Plan Pivots Sempra to Texas Transmission-Led, 95% Regulated Utility with No Equity Needs
Sempra used the Q4 2025 call to declare a strategic pivot. Management launched a record $65 billion 2026-2030 capital plan, largely concentrated in Texas transmission, and argued the company can fund ...
- Sempra delivered record full-year 2025 adjusted EPS of $4.69, at the high end of its guidance range; Q4 2025 adjusted EPS was $1.28 (GAAP Q4 $0.54).
- Management unveiled a $65 billion capital plan for 2026-2030, a 17% increase versus last year, with roughly 95% of spend targeted to regulated utility investments.
- Oncor/Texas drives the plan, with Sempra Texas rate base projected to grow at an 18% CAGR 2026-2030; overall company rate base is expected to rise from $57 billion in 2025 to $97 billion in 2030, an 11% CAGR.
- +12 more takeaways
HEICO Corporation Q1 2026 Earnings Call - Record earnings and strategic push into industrial gas turbines
HEICO posted a clean, profitable quarter: consolidated net income rose 13% to a record $190.2 million, or $1.35 per diluted share, with net sales up 14% and consolidated EBITDA up 14% to $312 million....
- Record Q1 net income of $190.2 million, up 13%, or $1.35 per diluted share; discrete stock option tax benefit was $21.8 million, lower than prior year’s $26.5 million.
- Consolidated net sales rose 14% and operating income increased 15%; consolidated EBITDA grew 14% to $312 million.
- Flight Support Group (FSG) led the quarter: net sales up 15% to $820 million, operating income up 21% to $200.7 million, and operating margin improved to 24.5% (cash EBITA margin ~27.1%).
- +12 more takeaways
The Pennant Group Fourth Quarter 2025 Earnings Call - 2026 Guidance Set Around Integration of Large Southeast Acquisition
Pennant closed 2025 with revenue of $947.7 million, adjusted EBITDA of $72.5 million, and adjusted EPS of $1.18, beating the midpoint of revised guidance. Management spent the call selling confidence ...
- Full-year 2025 results: revenue $947.7 million, adjusted EBITDA $72.5 million, adjusted diluted EPS $1.18, each at or above the midpoint of updated guidance.
- Large October 2025 acquisition added over 50 locations from UnitedHealth/Amedisys in the Southeast, plus Signature Healthcare at Home (closed Jan 1, 2025); management calls the Southeast deal the largest in company history and central to 2026 plans.
- 2026 full-year guidance: revenue $1.13B–$1.17B, adjusted EBITDA $88.5M–$94.1M, adjusted EBITDA prior to NCI $94.2M–$100M, adjusted EPS $1.26–$1.36; guidance assumes a phased ramp and integration noise in early quarters.
- +14 more takeaways
Cheniere Energy Fourth Quarter and Full Year 2025 Earnings Call - Completes 2020 Vision, Upsizes Buyback and Accelerates Brownfield Growth
Cheniere closed out 2025 with operational momentum and a capital-allocation mic drop. The company reported record production, strong fourth-quarter cash and earnings, and finished its 2020 Vision plan...
- Financials: Q4 consolidated adjusted EBITDA ~ $2.0 billion; FY2025 consolidated adjusted EBITDA ~ $6.94 billion (high end of guidance).
- Cash flow: Q4 distributable cash flow ~ $1.5 billion; FY2025 DCF ~ $5.3 billion, about $100 million above the high end of guidance.
- Earnings: Q4 net income ~ $2.3 billion; FY net income > $5.3 billion.
- +13 more takeaways
DXP Enterprises Q4 2025 Earnings Call - Record sales and margins, but energy backlog softens while debt and working capital climb
DXP closed fiscal 2025 with record sales and margin expansion, driven by a heavy dose of acquisitions and accelerating water-related project work. Full‑year sales rose 11.9% to $2.0 billion, consolida...
- Fiscal 2025 sales rose 11.9% to $2.0 billion, marking a company record.
- Consolidated gross profit margin expanded 67 basis points to 31.54% for 2025, driven by mix, pricing, execution, and accretive acquisitions.
- Adjusted EBITDA was $225.3 million, with an 11.2% margin, DXP's first full year above 11% adjusted EBITDA margins.
- +14 more takeaways
Koppers Holdings Inc. Q4 and FY 2025 Earnings Call - Catalyst delivered $46M in 2025, targeting $75M through 2028 to drive margins, cash and deleveraging
Koppers closed 2025 with stronger margins and cash generation despite a 10% decline in sales. Management reported adjusted EBITDA of $256.7 million and a company‑record 13.7% adjusted EBITDA margin on...
- Adjusted EBITDA for FY2025 was $256.7 million with a 13.7% adjusted EBITDA margin, a new as‑reported margin high water mark for Koppers.
- Catalyst transformation delivered $46 million of benefits in 2025 and management now expects up to $75 million of cumulative benefits across 2026–2028, with $20 million to $40 million targeted in 2026.
- 2026 consolidated sales guidance is $1.9 billion to $2.0 billion, with adjusted EBITDA guidance of $250 million to $270 million and adjusted EPS guidance of $4.20 to $5.00.
- +12 more takeaways
Marcus Corporation Fiscal 2025 Fourth Quarter Earnings Call - Capex Cut to Unlock Free Cash Flow After Hotel Renos, Theatres Outperform on Pricing and Family Slate
Marcus Corporation closed fiscal 2025 with a mixed but controlled finish. Consolidated Q4 revenue rose to $193.5 million, adjusted EBITDA was $26.8 million (up 3.6% year-over-year for the quarter), an...
- Consolidated Q4 revenue $193.5 million, up 2.8% year-over-year, consolidated adjusted EBITDA for Q4 $26.8 million, up 3.6% year-over-year for the quarter.
- Full-year adjusted EBITDA fell to $99.3 million, down 3.1% versus fiscal 2024, with full-year operating income $17.1 million (or $22.2 million excluding theatre impairments).
- Theatres recorded Q4 revenue of $123.8 million, a 2.2% increase, helped by a favorable fiscal calendar shift that added one net operating day and boosted admissions/attendance comparisons.
- +16 more takeaways
Global Net Lease Q4 2025 Earnings Call - Deleveraged to Investment Grade and Ready to Recycle Capital
Global Net Lease spent 2025 doing the heavy lifting. A $3.4 billion disposition program, capped by a $1.8 billion multi-tenant retail sale and the GBP 250 million McLaren campus sale, materially reduc...
- Transformation year: GNL sold about $3.4 billion of assets through 2025, simplifying the portfolio and cutting operational complexity.
- Flagship disposition: a $1.8 billion multi-tenant retail portfolio sale was the centerpiece of the program, accelerating deleveraging.
- McLaren sale detail: McLaren Campus sold for GBP 250 million (≈$336 million) at a 7.4% cash cap rate, generating ~GBP 80 million (≈$108 million) above original acquisition cost.
- +10 more takeaways
Crescent Energy Q4 2025 Earnings Call - Portfolio Upgraded, Strong Free Cash Flow and Crescent Royalties Launch
Crescent closed a transformational 2025 by executing roughly $5 billion of transactions, materially upgrading its portfolio and delivering cash-rich operations. Q4 production was 268,000 boe/d (106,00...
- Crescent executed nearly $5 billion of transactions in 2025, closing over $4 billion of acquisitions at under 3x EBITDA and divesting nearly $1 billion of non-core assets at over 5x EBITDA.
- Q4 2025 production was 268,000 boe/d, including 106,000 bbl/d of oil, with Adjusted EBITDA of ~$536 million and approximately $239 million of levered free cash flow.
- Management launched Crescent Royalties, a dedicated minerals/royalties platform; the minerals portfolio currently contributes about $160 million of annual cash flow and will be placed in a dedicated capital structure to scale.
- +11 more takeaways
Ecovyst Inc. Fourth Quarter 2025 Earnings Call - Debt Paid Down After AM&C Sale, Poised for Mining-Led Volume Growth as Sulfur Costs Rise
Ecovyst closed 2025 with a clean balance sheet and a clearer strategic path. A $556 million sale of the Advanced Materials & Catalysts business funded a $465 million paydown of the term loan, leaving ...
- Ecovyst delivered full year 2025 Adjusted EBITDA of $172 million, above prior guidance.
- Q4 2025 Adjusted EBITDA was $51 million, up 8% year over year despite regeneration volume headwinds.
- Q4 sales were $199 million, a 34% increase versus prior year; excluding a $28 million sulfur-cost pass-through, sales were up 15%.
- +14 more takeaways